Evidence map›Paper›PMID 21091062›Full record

Trial reportThe New England journal of medicine2010

In-center hemodialysis six times per week versus three times per week.

FHN Trial Group, Glenn M Chertow, Nathan W Levin, Gerald J Beck, Thomas A Depner, Paul W Eggers, Jennifer J Gassman, Irina Gorodetskaya, Tom Greene, Sam James and 15 more

Erratum issued 4 registry-linked trialsAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The New England journal of medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 4 registered trials, which are not on this map. Cited by 359 papers, 17 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
359citing papers in PubMed, 17 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00264758 phase2 / phase3completednot on this map

Frequent Hemodialysis Network: Daily Trial

TypeinterventionalSponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Ran2006 to 2010Enrolled245ConditionsEnd Stage Renal DiseaseArmsConventional hemodialysis, Frequent hemodialysis
NCT03759847 nacompletednot on this mapstarted 2019, after this paper: background citation

Fluid Intake App for Management of Volume Intake in Patients Receiving Chronic Hemodialysis Therapy

TypeinterventionalSponsorWake Forest University Health SciencesRan2019 to 2023Enrolled28ConditionsWeight GainArmsFluid intake app, Survey
NCT03994133 unknown statusnot on this mapstarted 2019, after this paper: background citation

Contribution of Body Composition Monitor (BCM) Among Patients Using Daily Home Dialysis With Low Dialysate Flow : French Study Cohort

TypeobservationalSponsorUniversity Hospital, CaenRan2019 to 2020Enrolled85ConditionsChronic Kidney Disease Requiring Chronic Dialysis, Hemodialysis, Home, Electric ImpedanceArmsMeasurement of the hydration state by bio-impedance spectroscopy
NCT04194164 nacompletednot on this mapstarted 2019, after this paper: background citation

Fluid Intake App for Management of Volume Intake in Patients Receiving Chronic Hemodialysis Therapy, Full Scale Trial

TypeinterventionalSponsorWake Forest University Health SciencesRan2019 to 2021Enrolled33ConditionsWeight GainArmsFluid intake app
3 · Its place in the literature

Who cites it

359 citing papers in PubMed, 17 syntheses or guidelines pooled it.

  1. Low dialysate sodium levels for chronic haemodialysis.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Home versus in-centre haemodialysis for people with kidney failure.The Cochrane database of systematic reviews · 2024
    Pooled it
  3. Simultaneous Heart and Kidney Transplantation: A Systematic Review and Proportional Meta-Analysis of Its Characteristics and Long-Term Variables.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Pooled it
  4. Pooled it
  5. Interventions for fatigue in people with kidney failure requiring dialysis.The Cochrane database of systematic reviews · 2023
    Pooled it
  6. Pooled it
  7. Guideline
  8. Pooled it
  9. Guideline
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Guideline
  14. Low dialysate sodium levels for chronic haemodialysis.The Cochrane database of systematic reviews · 2019
    Pooled it
  15. Pooled it
  16. Prognostic effect of high-flux hemodialysis in patients with chronic kidney disease.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2016
    Pooled it
  17. Pooled it
  18. Trial
  19. Trial
  20. Trial

299 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

FHN Trial Group
Glenn M Chertow
Nathan W Levin
Gerald J Beck
Thomas A Depner
Paul W Eggers
Jennifer J Gassman
Irina Gorodetskaya
Tom Greene
Sam James
Brett Larive
Robert M Lindsay
Ravindra L Mehta
Brent Miller
Daniel B Ornt
Sanjay Rajagopalan
Anjay Rastogi
Michael V Rocco
Brigitte Schiller
Olga Sergeyeva
Gerald Schulman
George O Ting
Mark L Unruh
Robert A Star
Alan S Kliger

Funding

Frequent Hemodialysis Network - West Coast ConsortiumU01DK066481 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHERTOW, GLENN MATTHEW · 2003 to 2010
$5.2M
Mentoring Patient-Oriented Clinical Investigators in NephrologyK24DK085446 · NIDDK · STANFORD UNIVERSITY · PI CHERTOW, GLENN MATTHEW · 2010 to 2022
$1.4M
NIDDK NIH HHS K24 DK085446NIDDK NIH HHS U01 DK066481
6 · The paper itself

Abstract

backgroundIn this randomized clinical trial, we aimed to determine whether increasing the frequency of in-center hemodialysis would result in beneficial changes in left ventricular mass, self-reported physical health, and other intermediate outcomes among patients undergoing maintenance hemodialysis.

methodsPatients were randomly assigned to undergo hemodialysis six times per week (frequent hemodialysis, 125 patients) or three times per week (conventional hemodialysis, 120 patients) for 12 months. The two coprimary composite outcomes were death or change (from baseline to 12 months) in left ventricular mass, as assessed by cardiac magnetic resonance imaging, and death or change in the physical-health composite score of the RAND 36-item health survey. Secondary outcomes included cognitive performance; self-reported depression; laboratory markers of nutrition, mineral metabolism, and anemia; blood pressure; and rates of hospitalization and of interventions related to vascular access.

resultsPatients in the frequent-hemodialysis group averaged 5.2 sessions per week; the weekly standard Kt/V(urea) (the product of the urea clearance and the duration of the dialysis session normalized to the volume of distribution of urea) was significantly higher in the frequent-hemodialysis group than in the conventional-hemodialysis group (3.54±0.56 vs. 2.49±0.27). Frequent hemodialysis was associated with significant benefits with respect to both coprimary composite outcomes (hazard ratio for death or increase in left ventricular mass, 0.61; 95% confidence interval [CI], 0.46 to 0.82; hazard ratio for death or a decrease in the physical-health composite score, 0.70; 95% CI, 0.53 to 0.92). Patients randomly assigned to frequent hemodialysis were more likely to undergo interventions related to vascular access than were patients assigned to conventional hemodialysis (hazard ratio, 1.71; 95% CI, 1.08 to 2.73). Frequent hemodialysis was associated with improved control of hypertension and hyperphosphatemia. There were no significant effects of frequent hemodialysis on cognitive performance, self-reported depression, serum albumin concentration, or use of erythropoiesis-stimulating agents.

conclusionsFrequent hemodialysis, as compared with conventional hemodialysis, was associated with favorable results with respect to the composite outcomes of death or change in left ventricular mass and death or change in a physical-health composite score but prompted more frequent interventions related to vascular access. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; ClinicalTrials.gov number, NCT00264758.).

Indexed as

AdultAgedDepressionFemaleHeart VentriclesHumansHyperphosphatemiaHypertensionKidney Failure, ChronicMagnetic Resonance ImagingMaleMiddle AgedRenal DialysisTreatment Outcome

Identifiers

PMID21091062
PMCPMC3042140

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.